展品10.1

SAMFINE CREATION HOLDINGS GROUP LIMITED

承銷協議

2024年10月14日

國泰證券股份有限公司

作爲若干承銷商的代表 名單上 附表A 此處

40 Wall Street, Suite 3600

紐約，紐約10005 美國

女士們，先生們：

以下籤署的人，Samfine Creation Holdings Group Limited，一家在開曼群島註冊的豁免公司（以下簡稱“公司”），特此確認其與Cathay Securities，Inc.（以下簡稱“協議”) with Cathay Securities, Inc. (hereinafter referred to as the “代表人以及本委託書所列出的其他承銷商（代表人及其他承銷商合稱「承銷商」；但如時間表1上無額外承銷商，則本協議中的「代表人」將表示爲承銷商，如本協議只針對一名代表人，則「代表人」的術語將表示爲此收件人，「代表人」和「承銷商」這些術語應根據上下文而定）的代表（以下簡稱「代表人」） 附表A 並與本委託書所列出的其他承銷商（代表人及其他承銷商合稱「承銷商」；但如時間表1上無額外承銷商，則本協議中的「代表人」將表示爲承銷商，如本協議只針對一名代表人，則「代表人」的術語將表示爲此收件人，「代表人」和「承銷商」這些術語應根據上下文而定）的代表（以下簡稱「代表人」）達成協議承壓商「股份」或單獨稱爲「穩定的股份」票據的購買金額” 具體如下：發行並賣出公司的2,000,000股普通股給承銷商。本協議所規定的證券發行和銷售在此稱爲“增發計劃.”

1. 公司股份；額外股份.

(c) 額外普通股本公司特此向承銷商授予選擇權（「選擇權」），即購買最多 [●] 的額外股份。超額配售選擇權）可以購買最多300,000股普通股（“附加股份），每種情況僅用於彌補超額配售的證券份額，佔發行公司股票15%。

(d) 超額配售權的行使 選擇。根據本證券發行後超額配售選擇權可由 第1(c)條款 本處的選擇可以全數或部分在生效日期後45天內行使。每股額外股份應支付的購買價格應等於每股一致股份的價格 在 本章第1條(a)款。承銷商無需在行使 之前購買任何額外股份 超額配售權。此處授予的超額配售權可以在最少提前兩個完整工作日發出書面通知後行使 Underwriters向公司提出，指定要購買的額外股份數目 Underwriters支付額外股份的日期和時間（“選擇權收盤日）， 截止日期不得晚於書面購買補充股份的通知日期之後的五（5）個完整工作日，或公司和承銷商一致同意的其他時間，在承銷商的律師事務所辦公室 或公司和承銷商一致同意的其他地點（包括遠程傳真或其他電子傳輸方式）。 如果在截止日期未交付補充股份並支付款項，則選擇行權日期將 如書面通知中所述。按照本文所述的條款和條件行使關於所有或任何部分補充股份的超額配售選擇後（i）公司應該義務向承銷商賣出在此類通知中指定的 補充股份數量，並且（ii）承銷商應當從公司購買正在使用折價股份數量購買的補充股份總數的那部分，其中該部分與固定股份數量的數量一表 附表A 相對於所有承銷商的名稱 與所有已發行股份總數相比，但須根據承銷商自行判斷進行調整。

(e) 額外股份數量的交付和支付。額外股份數量的支付應於「期權結束日期」通過電匯以聯邦（當日）資金方式進行，同時在「期權結束日期」將額外股份交付給承銷商，通過DTC的設施存入承銷商的帳戶。額外股份數量應按照承銷商在「期權結束日期」前至少兩（2）個完整工作日書面請求的姓名或名稱和授權面額進行註冊。除承銷商支付相應額外股份數量的款項外，公司不得有義務出售或交付額外股份數量。期權結束日期可能與結束日期同時但不得早於結束日期；如果此時間和日期與結束日期同時發生，則術語「結束日期」將指交付穩定股份和額外股份的時間和日期。

公司股份和額外股份以下統稱“證券.”

2. 公司的陳述和擔保公司在適用時間（如下定義）和截止日期向承銷商作出如下陳述和保證：

(a) 註冊申報表的提交.

(i) 根據該法案.

(1) 本公司已向 美國證券交易委員會（」委員會」) 註冊聲明及修訂或修訂 其上載於表格 F-1（檔案編號 333-275498），包括任何有關證券登記的招股章程或宣傳單張 一九三三年證券法（經修訂）（」法案」)，有哪些註冊聲明及修訂或修訂 由本公司準備，並在所有重要方面符合本法的要求和委員會的規則和法規 根據法例（」規例」)。除情況下另有規定外，此類註冊聲明會在檔案中 註冊聲明生效時向歐洲委員會（包括招股章程、財務報表、附表、 展品，以及作為其一部分提交或納入其中的所有其他文件，以及截至以來被視為其一部分的所有信息 註冊聲明的生效日期（」生效日期」) 根據《規例》第 430A 條第 (b) 段)， 在此被稱為」登記聲明.

(2) 輔導承銷商首次提供用於發行的最終招股說明書，以下簡稱「招股書.”

（3）註冊聲明已於本日期或之前獲得委員會宣佈生效。適用時間“時”指本協議日期當天下午五時東部時間，或公司與承銷商同意的其他時間。

(ii) 根據《證券交易法》登記。證券已依據1934年證券交易法第12(b)條的規定註冊（以下簡稱為“交易所法”）公司未採取任何旨在終止證券根據交易所法案進行登記，也未收到任何指示，表示委員會正在考慮終止該等登記，除非在註冊聲明書和招股書中另有說明。

(iii) 上市在納斯達克。 股票將在結業日期前獲批列入納斯達克資本市場，須等官方通知發行，且公司沒有採取任何旨在終止在納斯達克上市的行動，也不可能導致這種情況，亦未收到任何納斯達克正在考慮撤銷或撤回證券上市批准的通知。納斯達克）到結業日期時，股份將獲得納斯達克資本市場上市的批准，需等官方通知發行，且公司未採取旨在終止在納斯達克上市證券的行動，亦未收到任何納斯達克正在考慮撤銷或撤回上市批准的通知。

(b) 沒有止損訂單，乙太經典。 就公司所知，沒有任何委員會或任何州立監管機構發出任何阻止或暫停使用任何初步說明書（乙太經典）、招股書或登記申報書的命令。初步說明書），招股書或登記申報書的使用，也沒有就該等命令採取任何程序，或就公司所知，有任何威脅採取任何相關程序。

(c) 申報書中的披露 聲明.

(i) 100億5代表.

(1) 登記聲明書 以及任何後續生效修訂，在其生效時，所有實質方面均符合 法案和法規的要求。

(2) 註冊聲明生效時，及其任何修訂或補充，不包含並且在結束日期時，將不包含任何不實的重大事實陳述或遺漏任何需要在其中說明或在制作聲明時必要之重要事實，考慮當時的情況，不是誤導的。提交給委員會時的招股說明書不包含並且在結束日期時，將不包含任何不實的重大事實陳述或遺漏任何需要在其中說明或在制作聲明時必要之重要事實，考慮當時的情況，不是誤導的。本部分2(c)(i)(2) 中所做的陳述和保證不適用於以依賴並符合向公司提供的有關包商的書面資訊為依據或遵循而作出或遺漏的陳述，以明確用於註冊聲明或招股書或其任何修訂或補充。各方承認並同意，由包商提供或代表包商提供的該信息僅包含招股說明書“包銷”部分中所包含的披露（統稱為“ Section 2(c)(i)(2) ”承銷商資訊”).

(3) 一般披露文件包括下列定義的意義 ，當與招股書一起作為整體來看時（合稱為“披露材料”）， 在發表之時的背景下，該等文件中不包含任何關鍵事實的不實陳述，或者遺漏任何必要的關鍵事實以使其陳述不具有誤導性。上述句子不適用於根據和符合承銷商資訊的披露資料中的語句 或遺漏。

(ii) 股份先前的交易公司未賣出任何證券，也未由公司或代表公司或為公司利益的其他人或人士出售，控制或被控制，以及與公司共同控制的，除了在登記聲明書和招股書中披露的情況。

(d) 在登記申報書中日期後的更改.

(i) 無重大不利變動。. 自最新經過審核的基本報表中涵蓋的期間結束以來，以及唯有在註冊申請及招股說明書中另有特別指明的情況下，公司據其所知并未發生任何可能對其造成重大不利影響（如下所定義）的事件；並且公司亦未進行任何非業務常規性交易，除了根據本協議所預期的。

(ii) 最近證券 交易等自最新經過審計的基本報表所涵蓋期間結束以來，以及除非另有說明或在此處或在註冊聲明書和招股書中披露的情況下，公司沒有，除了與以當時普通股公平市價相等的行使價格購買普通股的期權有關的事項外，向員工、顧問或服務提供者發行任何證券或承擔任何大額負債或債務，直接或間接，除非屬於業務普通運作範疇; 或(ii) 宣布或支付任何股息或轄其股本享有其他分配。

(e) 獨立會計師據公司所知，報告已提交到委員會的WWC, P.C.（“WWC”）是獨立的註冊會計師，符合法令的要求。

(f) 財務報表 等等。財務報表，包括註冊聲明及招股章程中的附註及附表， 公平地呈現本公司適用日期及期間的財務狀況及營運結果； 此類財務報表已根據美國一般公認的會計原則擬備（」高爾夫」)， 在所涉及的期間一致地應用，除非在其中披露；以及註冊中包含的附屬表 聲明公平地呈現在該聲明中所需的資料。註冊聲明披露所有重大非餘額 表單交易、安排、義務（包括可定義務）以及公司與未合併的其他關係 可能對本公司財務狀況、財務變化產生重大影響的實體或其他人士 狀況、營運結果、流動性、資本支出、資本資源或收入或支出的重要組成部分。 除註冊聲明和招股章程中披露的情況外，(a) 本公司及其任何營運子公司（每個、 一」子公司，」和一起，」子公司」)，已承擔任何重大責任或義務， 直接或有條件，或進行任何其他重大交易以外，(b) 本公司沒有 就其股本聲明或支付任何股息，或作出任何形式的分配；(c) 沒有發生任何變化 在本公司或其任何附屬公司的股本或任何股票補償計劃下的任何補助金，而 (d) 沒有 本公司的長期或短期債務有任何重大不利變化。

(g) 已授權資本; 期權、乙太經典公司在登記聲明書和招股書中設定的已授權、已發行和已流通資本。基於登記聲明書和招股書中所述的假設，公司將在結算日期具有該處所載的調整資本結構。除本協議所載或預料到的之外，在生效日期和結算日期，公司將不會有購買或以其他方式取得公司已授權但未發行的股本或可轉換為公司股本的任何安防，或發行或賣出股本或任何此類期權、乙太經典、權利或可轉換證券的任何合約或承諾。

(h) 證券的有效發行， 等。

(i) . 所有在本協議所涉及的交易之前發行的該公司優秀證券均經適當授權並有效發行，已全額支付且無需進一步徵收款項；該公司之證券持有人對其擁有的證券沒有回購權，并且不因為成為此類持有人而承擔個人責任；且這些證券沒有違反該公司任何證券持有人之先買權或類似的合同權利。。所有板塊在本協議所倡議之交易前發行的所有已發行和未解決的證券均已正式授權發行，並已全額支付且不須進行處分（此術語用於指公司股份之股東無需支付任何進一步款項與其有關）；其持有人對此沒有撤銷權利，並且不因為是這些持有人而面臨個人責任；且這些證券中沒有違反公司任何證券持有人的優先購買權或類似公司授予的合同權利。

(ii) 根據本協議出售證券這些證券已經獲得授權發行和銷售，並且在發行時已支付，將被有效發行，全數支付並且無需進一步徵收（此術語用於指公司股份時，指出其持有人無需支付任何額外款項與其發行有關）；這些證券並不且不會受到公司股份持有人的預先購買權或公司授予的類似合同權利的約束；為授權、發行和出售上述證券所需採取的所有公司行動已被適當且有效地採取。這些證券在所有重要方面符合註冊聲明中有關其的所有陳述事項。

(iii) 證券發行。 證券發行後，根據本合同的條款，承銷商全額支付該等證券後，這些證券將依法有效發行，登記持有該等證券的人將有權享有證券中規定的權利，在根據本協議出售並交付這些證券並支付相應款項後，登記持有該等證券的人將擁有該等證券的良好、具有銷售性質和有效產權，免除任何抵押、留置權、安全權益、負債、索賠或任何形式的負擔。

(i) 第三方的登記權 . 除了在登記表和招股書中註明的情況外，公司的任何證券持有人或任何按行使權利或可轉換成公司證券的權利的人均無權要求公司根據法案登記公司的任何此類證券，或在由公司提交的登記申報書中包括任何此類證券。

(j) 本協議的有效性和約束力。本協議已獲得公司的適當和有效授權，且當由公司代表或代表公司簽署和交付時，將構成公司的有效且具約束力的義務，按照其條款可供建得。除非：(i)該執行可能受限於破產、無力償還、重整或類似影響債權人權利的法律而限制，(ii)任何賠償或貢獻條款的執行可能受到聯邦及各州證券法的限制，以及(iii)特定履行、禁制令及其他形式的衡平救濟可能受衡平辯護和法院裁量的管轄，因此可能提起任何訴訟。

(k) 沒有衝突本協議之執行、交付和履行，本公司在此及其中交易的完成以及本公司對本協議條款的遵守，不會且不會，無論是否發出通知或經過時間或兩者：(i) 導致對本公司任何協議或文件條款和條文違反的重大違約，或產生衝突；任何財產或資產產生、修改、終止或設定任何抵押權、負擔或留置權，依據本公司為當事方之任何協議或文件條款；(ii) 導致違反本公司修訂後的公司備忘錄和章程的規定，(如隨時修訂的，以下簡稱為「本章程」)；或(iii) 違反任何現行適用的法律、規則、條例、判決、訂單或裁定，由任何有管轄權的政府機構或法院（包括國內或外地）對本公司或本公司及其財產或業務所構成的截至本協議日的狀況所管轄，除非出現違反或違約，理應不會合理預期對本公司資產、業務、狀況、財務狀況或營運結果構成重大不利影響（「公司重組證明（"Charter"））」。重大不利影響”).

(l) 沒有違約；違規情況。 就借款 货的义务所指明的任何条款、契约或控制項、抵押、信托契据、票据、贷款或信用协议、或公司一方或公司所受约束或公司的任何資產受约束的其他具体义务的任何其他材料协议或工具的履行和遵守中不存在违约，但遭遇到這類单独或单独来看不會对公司及其附属公司作为一个整体构成重大不利影响，且不会或未公开在注册声明、招股说明书或披露材料中。公司不违反章程的任何条款或规定，也不违反公司在管辖公司或其資產或业务的任何法定机构或法院的条例、许可证、适用法律、规则、法规、判决或法令的任何方面，但遭遇到這類单独或单独来看不会对公司及其附属公司作为一个整体构成重大不利影响，且不会或未公开在注册声明、招股说明书或披露材料中。

(m) 企業權力; 許可證; 同意.

(i) 業務的進行. 除了註冊聲明和招股說明書中所述之外，公司具有所有必要的公司權力和授權， 並且擁有自本日起談談進行業務目的所需的所有政府監管官員和機構的授權、批准、命令、執照、證書和許可， 除非在每種情況下都不會合理預期對實體不利影響。

(ii) 所有板塊交易 此中。該公司擁有所有企業權力和權限來訂立此協議並實施此協議及此協議和相關文件中的條款和條件，並已取得一切在相關方面所需的所有同意書、授權、批准和命令。就有效發行、銷售和交付證券及公司實施本協議所涉及的交易和協議，以及根據招股書所預計的交易和協議，除了適用的聯邦和州證券法律、以及金融業監管局的規則和法規外，無需獲得任何法院、政府機構或其他機構的同意、授權或命令，也無需提交任何申請。FINRA”）及納斯達克。

(n) D&O問卷根據公司所知，問卷中所包含的所有信息（“問卷”）由發起人、公司的高層管理人員和董事在發行前立即完成並提供給承銷商，這些信息均真實無誤，且公司沒有得知任何可能導致每位內部人士填寫的問卷中的信息不準確和不正確的情況。問卷所有板塊在招股書提供前已由招股章程中名列的公司董事和高級主管完成"管理"部分。在為其他有價值的考慮下的情況下，為了促使公司和承銷商簽署承銷協議，進行公開發行以及出於其他良好的金錢考慮，Smilodon Capital，LLC，一家特定負責有限責任公司，以及公司董事會和/或管理團隊的成員（每位簽署人，皆為“公司內部人士”）在此同意以下事項：）並且向承銷商提供的所有內幕人士填寫的問卷資料，在所有方面均為真實正確，且公司未得悉任何可能使內部人士填寫的問卷資料變得不準確和錯誤的信息。

(o) 訴訟；政府 程序除了在登記聲明書和招股書中披露的事項外，目前或聲稱針對公司進行的任何訴訟、訴訟、程序、調查、仲裁、調查、訴訟或政府程序，或與公司有關的，或公司知情的，尚未在登記聲明書和招股書中披露，或者與公司的證券在納斯達克上市的申請有關的，沒有進行中或尚未得到公司知情的執行官或董事涉及的。

(p) 良好的信譽隨函附上，公司已經合法成立，根據開曼群島法律生效並有效存在，截至今日，公司在所在地的業務需求的每個司法管轄區均已合法適格並且持續有效存在，除非未取得合格資格可能不會合理預期對公司產生實質不利影響。

(q) 影響揭露給FINRA的交易.

(i) 傭金。 除註冊申報書和招股意向書中所述外，公司或任何內部人士與本次證券銷售有關的查找人員、諮詢或創始費用付款、安排、協議或理解，以及公司或公司所知，可能影響承銷商酬金的任何其他安排、協議或理解，如FINRA所確定的。

(ii) 十二個月內的付款除非在登記文書和招股書中有所描述，公司在生效日期前的十二個月內，沒有直接或間接向任何人（以現金、證券或其他方式）支付過：（i）作為尋找費、諮詢費或其他形式的慰問費，作為考慮向該人為公司籌集資金或向公司介紹籌集或提供資金給公司的人；（ii）向任何FINRA成員；或（iii）向在生效日期前十二個月內與任何FINRA成員有任何直接或間接聯繫或關聯的人或實體支付過任何款項，除了在2022年和2023年向公司前承銷商Univest Securities LLC支付的129,100美元款項，在本次發行中提供如下。

(iii) FINRA 隸屬。 據本公司了解，除非曾向承銷人書面披露，否則沒有任何內部人或持有本公司10%或以上普通股的受益人直接或間接與任何FINRA成員有聯繫或聯繫（根據FINRA的規則和法規確定）。

(iv) 募集款項用途。 發行所得的任何淨收益均不得由公司支付給任何參與的FINRA會員或其附屬機構，包括在美國以外的任何國家或司法管轄區內的任何FINRA會員或其附屬機構，除非在本文件中特別授權。

(v) 資訊。 所有板塊 公司在其提交給承銷商律師的FINRA問卷中提供的所有資訊，專門供承銷商律師在與FINRA的公開發行系統申報（以及相關披露）中使用，就重要事項而言都是真實、正確且完整的。

(r) 外國腐敗行為法。 公司或根據公司所知，公司的任何內部人員或員工，或公司的任何其他人員授權代表公司行事，均未直接或間接地明知地向任何顧客、供應商、員工或代理商、任何政府機構或政黨（國內或國外）的官員或員工，或國內或國外的政黨或候選人，或可能處於幫助或阻礙公司業務（或協助其有關任何實際或拟議之交易）之人士，直接或間接地提供或同意提供任何金錢、禮物或類似利益（除了公司在業務平常運作中向顧客提供合法的價格優惠外），該行為可能使公司遭受任何民事、刑事或政府訴訟或訴訟中的損害或處罰。

(s) 主管證明書。 任何由公司的任何授權主管簽署並交付給您或承銷商顧問的證書，將被視為公司向承銷商對所涵蓋事項作出的陳述和保證。

(t) 鎖定期限。

(i) 每位內部人員（」鎖定 派對」) 已根據已簽署的鎖定協議 (以本文附表格) 同意為 附件一 （對於官員， 董事及 5% 或以上股東），即在發售開始銷售日期後六 (6) 個月結束的期限 （」鎖定期間」），每個該等人士及其各自的關聯人不得提供、擔保、出售、合約 直接或間接出售、授予、借出或以其他方式轉讓或出售本公司的任何證券或股本，包括 普通股，或任何在未經同意的情況下可轉換成或可行使或可兌換該等證券或股本的證券 承保人的，但某些例外情況除外。如果以下情況，承保人可同意從適用鎖定期間提前釋放： 根據其認為，證券市場不會受到銷售及鎖定的財務緊急情況下不會受到負面影響 派對。

(ii) 公司代表自身及任何繼承實體同意，在銷售發行股票的日期起計的三 (3) 個月內，未經承銷商事先書面同意，不得 (i) 提供、質押、賣出、訂約賣出、出售任何選擇權或購買合約、購買任何選擇權或賳本或可轉換為或行使或可兌換公司股權的任何證券、授予任何購買權利或認股權證、借出，或直接或間接地轉讓或處置公司股本的任何股份或任何可轉換為或行使或可兌換公司股份的證券，(ii) 提出或促使提交任何向委員會相關的登記聲明，涉及公司股份或任何可轉換為或行使或可兌換公司股份的證券的發行，或 (iii) 進行任何 swap 或其他安排，將公司股本擁有權的任何經濟後果全部或部分轉移給另一方，無論任何上述條款 (i)、(ii) 或 (iii) 描述的任何該交易是通過提供公司股份或其他證券，以現金或其他方式進行了結。本條所載的限制 第 2(t)(ii) 條款 不適用於 (i) 本次銷售的證券，(ii) 公司依據本日期設立的已發行的任何選擇權或認股權證的行使發行的證券，前提是在本日期之前已經書面通知承銷商有關發行，(iii) 公司根據本日期之前有效的任何公司股票酬勞計劃下的認股選項或證券發行，(iv) 任何 Form S-8 的登記聲明，或 (v) 用於與併購、收購、合資、授權安排或任何其他類似的非資本籌資交易中發行的證券，前提是這些股份未根據登記聲明進行登記。對於本段落中子條款 (ii) 的目的，承銷商承認在本日期之前提交登記聲明時所披露的任何未行使的選擇權或認股權證應被視為對承銷商事先書面通知。

(u) 附屬機構在登記聲明書的附件21.1中列出了公司的每個子公司和合併實體，並說明了每個子公司的成立司法管轄權。這些子公司根據其成立地或註冊地的法律合法組建並處於良好地位，每個這樣的子公司在其擁有或租賃財產或開展業務所需的每個司法管轄區中均處於良好地位，除非未取得資格的後果不會合理預期對其產生重大不利影響。公司對每個子公司的擁有和控制，以及每個子公司對其他子公司的擁有和控制如登記聲明書、披露資料和招股書所述。公司不直接或間接擁有或控制任何公司、協會或實體，除了在登記聲明書和招股書中披露的情況。公司及其子公司都具有充分的公司權力和授權，按照披露資料和招股書所述擁有或租賃財產，並運營其業務，並且在每個需要取得資格的司法管轄區下都取得了根據法律要求的營業資格。

(v) 相關方交易。 除了在註冊聲明和招股說明書中披露的內容外，公司或其他人沒有任何需要在招股說明書中描述但未如所需描述的業務關係或相關人士交易。

(w) 董事會。 本公司董事會由括在招股章程“管理層”的人士組成。擔任董事的人士的資格及董事會的整體組成符合2002年《薩班斯-豪利法案》及其以下適用於本公司和納斯達克的法規。本公司的董事會至少有一名成員符合《薩班斯-豪利法案》及其以下法規以及納斯達克的規定的“審計委員會財務專家”資格。此外，本公司董事會至少有多數成員符合納斯達克的規定中定義的“獨立董事”資格。

(x) 遵守薩班斯-豪利法案。 除了在註冊申報、披露資料和說明書中描述的內容外，公司在生效日期時將會基本符合2002年Sarbanes-Oxley法案適用的規定並實施或將實施相應的計畫，並採取合理措施確保公司未來合法遵循Sarbanes-Oxley法案的所有重要規定（不會遲於相關的法定和監管截止日期）。

(y) 無投資公司 狀態。本公司不會且在進行發售證券，並根據註冊聲明和招股書所述的淨收益之用途後，不會成為根據1940年修訂版的《投資公司法》定義的“投資公司”。

(z) 沒有實質性勞資紛爭。。 公司或其任何子公司的員工之間並不存在任何勞資糾紛，亦非據公司所知即將發生的， 可能導致重大不利影響。

(aa) 知識產權除非在登記聲明和招股書中另有描述，公司及其各附屬公司擁有或擁有使用所有專利、專利申請、商標、服務標誌、商號、商標註冊、服務標誌註冊、版權、許可證、發明、商業秘密和類似權利（"知識產權所需進行業務的知識產權，公司及其附屬公司目前進行的業務和在登記聲明和招股書中描述的業務所需的，除非沒有擁有或擁有相應權利將不能合理預期會導致重大不利影響。據公司所知，公司或其任何附屬公司的行動或使用將不涉及或引起對他人的任何知識產權的侵權，或對任何知識產權支付重大許可費用或類似費用，合理預期會對公司及附屬公司整體造成重大不利影響，除非在登記聲明或招股書中披露。公司或其任何附屬公司沒有收到任何指控有關此類侵權或費用的通知，除非此類侵權或費用不合理預期會對公司或附屬公司整體造成重大不利影響。

(bb) 稅收所有板塊和其附屬機構已在此前提交所需提交的所有報稅（如下所定義），並已正式取得延長提交期限。所有板塊和其附屬機構已支付所有應在此類報稅中列明為逾期款項的稅款（如下所定義），並已支付對公司或其附屬公司徵收的所有重要稅項。與或作為登記聲明一部分而提交的財務報表中顯示的應付稅項預留金，如有，足以支付所有應計未付稅款，無論是否有爭議，直至該等綜合財務報表截至日期。除非書面披露給承銷商及公司知曉，（i）在有關的任何報稅或稅項中，任何稅務機關尚未提出重要問題（現時未了結），並且（ii）未曾由公司或其附屬機構就報稅或稅款徵收事項發出或接獲時效保留豁免。術語“稅收” 意指所有聯邦、州、地方、外國和其他凈利潤、總收入、總收入、銷售、使用、徵收、轉讓、特許、利潤、承租、租賃、服務、服務使用、扣繳、薪資、就業、消費稅、分離財、郵票、職業、高額奬金、財產、意外利潤、關稅、稅項或其他任何種類的稅收、費用、評估或任何性質的收費，以及有關任何利息和任何懲罰、增加稅收或額外金額。該術語“申報” 指所有應向有關稅務機關提交的申報書、申報、報告、陳述和其他有關稅收的文件。

(cc) 資料。所載於《登記聲明書》和《招股說明書》中的統計、與行業相關以及市場相關數據均是基於或衍生自公司認為可靠準確的來源，且該等數據與其衍生來源一致。公司已獲得從相應來源獲得這些數據使用的書面同意書，以確保必要的部分。

(dd) 董事會。 公司的董事會合法任命了符合納斯達克規則和公司董事會及/或審計委員會要求的審計委員會，並且董事會和/或審計委員會已採納符合納斯達克規則和法規要求的憲章。除在註冊聲明和招股書中披露的事項外，公司的董事會或審計委員會未接獲過，亦無任何公司董事知曉，影響公司記錄、處理、概括和報告財務資訊的內部財務控制設計或操作中任何重大缺陷和實質弱點。

(ee) 沒有整合。 在此日期之前，公司或任何子公司並未發出或銷售任何證券，該證券根據法案或法規要求與根據登記聲明進行的承銷商的發行和銷售進行“整合”。 除在登記聲明中披露的情況外，公司或任何子公司在招股書日期前的六個月期間，未銷售或發行任何普通股或任何可轉換成普通股、可行使或交換為普通股的證券，或其他權益證券，或購買任何公司普通股或其他權益證券的權利，包括但不限於根據法案下的144A條或D條或S條進行的任何銷售，其次除了根據員工福利計劃、符合員工股票選擇計劃或員工酬金計劃發行的普通股，或根據登記聲明中描述的擁有的期權、權利或認股權證之外。

(ff) 中國人民共和國、香港、英屬維爾京群島、開曼群島和美國的陳述與保證.

(i) 組織。 附屬公司已經合理組織，並根據人民共和國適用法律有效地存在為公司 中國 (」中國」)、香港及英屬維爾京群島（「英屬維爾京群島」），以及對本公司的 中國附屬公司、本公司的中國附屬公司均已妥善組織，每個公司均以法律有效的形式存在 中華人民共和國，其營業執照完全有效；三芬印刷（深圳）有限公司已符合資格 擁有營業執照的外商投資企業。中國附屬公司的 100% 股權均由本公司擁有 本招股章程所述，而該等股票權益不包括所有抵押、擔保、股票或索償；該章程， 中國附屬公司的營業執照及其他成份文件在所有重要方面都符合以下規定 中華人民共和國適用法律，並具有完全有效力和效力；公司擁有全部權力和權力（公司和其他）和所有同意， 任何政府機構的批准、授權、許可證、許可證、許可證、訂單、註冊、通關和資格 對中國附屬公司或其擁有或租賃財產所需的任何物業管轄權，以及 根據其註冊業務範圍進行業務，除非合理預期不合理的情況下進行業務 具有重大不利影響，並具有擁有、使用、租賃和運營其資產以及開展其業務的法律權利和權力 以目前進行的方式和說明書中所述；以及深圳三芬雲端印刷技術的註冊資本 Limited 尚未全額支付，這不違反公司章程和適用的中華人民共和國法律。

公司所有財產和資產的法律標題均合法有效，不受任何留置權、抵押、質押、股權、索賠、期權和限制的限制；每份租賃協議均經適當執行並在法律上具約束力；其租賃權益均列明並受任何租賃協議的條款支配，據公司所知，該等協議均根據中華人民共和國法律在其各自條款下有效、具約束力且可強制執行，除非該等租賃協議的無效會合理預期對公司或中華人民共和國子公司整體產生實質不利影響的情況除外；且公司或中華人民共和國子公司均無任何其他重要不動產的所有權、營運、管理或其他權利或利益，該等情況將合理導致公司及中華人民共和國子公司整體產生重大不利影響，除招股書所述。

(ii) 稅收除非在註冊聲明、披露材料和招股說明書中另有披露，否則在中國大陸、香港或開曼群島與任何中國大陸、香港或開曼群島稅務機構就（A）向購買者發行、出售和交付證券，以及（B）從公司購買並將證券出售和交付給購買者時，不需支付任何交易、印花、資本或其他發行、註冊、交易、轉讓或預扣稅款。

(iii) 分紅派息除非在披露文件、登記聲明和招股書中另有披露，公司的任何子公司目前沒有被直接或間接禁止或限制，不能向公司支付任何分紅派息，不能對其資本股進行任何其他分配，不能向公司償還公司向該子公司提供的任何貸款或預付款，也不能將該子公司的任何財產或資產轉讓給公司或公司的任何其他子公司。

(iv) 洗錢。 公司及其子公司的運作始終在所有重大方面都遵守貨幣洗錢法規的財務記錄和報告要求，以及由任何政府機構制定、管理或實施的任何相關或類似的規則、法規或指引（統稱“ ”），並且沒有任何法院、政府機構、權威機構或機構或任何仲裁人介入的訴訟或訴訟程序涉及公司或其任何子公司。洗錢法規

(v) 美國財政部外國資產控制辦公室據公司所知，公司的董事、高級管理人員或員工，以及其附屬公司，均未進行或簽訂與政府或政府部門的交易，或與美國財政部外國資產控制辦公室管理的目前受制裁的國家的居民，或任何總部或居住於此等國家的實體的交易。 OFAC 公司或其附屬公司目前並不受美國財政部外國資產控制辦公室（包括但不限於“特別指定國民或受封鎖人士”）所管理的任何美國制裁的影響，亦不受聯合國安全理事會、歐盟所實施的制裁影響，且不位於、組織在、或居民於受OFAC管理的制裁的國家或地區，包括但不限於緬甸/緬甸聯邦、古巴、伊朗、朝鮮、蘇丹和敘利亞；公司也不會明知地直接或間接使用本次發行的款項，或對任何附屬公司、合資企業伙伴或其他人或實體進行貸款、貢獻或以其他方式提供該等款項，以資助目前受到OFAC管轄的任何美國制裁的人士的活動。

(vi) 沒有豁免權。 公司及其子公司或其或其產業或資產資產，從來沒有對開曼群島、香港、中國內地、紐約或美國聯邦法律所轄制庭或人士做出的豁免（不論是通過傳票或通知、在判決前的扣押、為協助執行的扣押或其他方式）；且在任何時候公司、其子公司或其各自的產業、資產或收入或許擁有或稍後或許會有權享有此等豁免權的律師制法院時，公司及其子公司分別放棄或將放棄這類權利，並已同意在本協議中條款下，根據紐約法律就提供的此類救濟及強制執行。

(vii) 分紅派息或分配的自由轉讓。 除了在披露資料、註冊聲明書和招股書中公開披露的情況外，所有普通股股息和其他分配可能根據現行開曼群島、BVI、香港和中國法律和規定支付給美元持有人，並可能轉換為可根據贊美群島、香港和中國的法律和規定轉移到境外的外匯，所有支付給開曼群島、香港和中國的非居民持有人的支付，均不受開曼群島、香港或中國法律和規定，或任何政治分區或該等法執權或所述法執權，的所得稅、扣繳稅或其他稅收影響，並且在開曼群島、香港和中國或任何該等地區的政治分區或課稅機構或所述地區的課稅機構，均無需任何其他稅項、費用、扣繳稅款或扣減款，無需在開曼群島、香港或中國或任何該等地區的政治分區或課稅機構或所述地區的課稅機構, 取得任何政府授權，而且無需取得這些授權。

(vii) 不是一個PFIC除非在披露資料、登記聲明和說明書中另有披露，公司不認為其將被視為被動外國投資公司（"PFIC）"據美國1986年修訂版《美國內部稅收法》第1297條的定義，在其本稅收年度內。公司對於以一種在今後稅收年度中合理預期將導致公司成為被動外國投資公司的方式經營沒有計劃或意圖。

(ix) Foreign Private Issuer Status. The Company is a “foreign private issuer” within the meaning of Rule 405 under the Act.

(x) 選擇法律除非在披露文件、註冊聲明和招股說明書中另有披露，本協議中規定的法律選擇條款構成開曼群島、香港和中國內地法律下的合法和有效的選擇，並將得到開曼群島、香港和中國內地法院的尊重，但須遵守相關的民事訴訟程序要求（不涉及對主張的重新審查）在開曼群島、香港和中國內地。公司有權提交，並根據法律執行， 根據本協議第14節， 公司有權指定、委任和授權，並根據本協議第**節，已合法、有效並不可撤銷地指定、委任了服務程序的授權代理，以便在任何因本協議或證券而在任何紐約法院提起的訴訟中接受法律程序，對該授權代理進行的法律程序將有效地賦予公司有效的個人管轄權，如所提供的 第14節 代理將是有效的，可以確立對公司的有效個人管轄權。 第14節 本協議第

(xi) 裁決的承認。 任何在紐約法院根據本協議具有管轄權以紐約法律爲依據對公司提起的任何 訴訟 。 訴求 或程序的最終判決，在 大開曼群島法院會被承認並執行，無需重新審查案件的情況根據義務的普通法條規；前提是該判決(A)由有管轄權的外國法院 作出 ；(B) 把判決的被執行人 作出一項要求支付已經被給予判決的清償金額的責任；(C) 是最終的；(D) 不涉及稅務、罰款或處罰；(E) 不是以違背大開曼群島自然正義或公共政策爲基礎來獲得和執行的。

(xii) 證監會申報。 公司在申報程序中提供的信息（證監會申報”）根據境外公司境內上市境外證券發行與上市試點管理辦法及其指引（統稱“試行辦法”） 由證監會發布的所有資料均在所有重要方面均屬真實準確，未有隱瞞任何重大事實使其具有誤導性。

(gg) MD&A本章節名爲“分銷計劃”的內容在《初步招股說明書》與《招股說明書》中準確完整地描述了以下重要內容： (A) 公司認爲在展示公司財務狀況和經營業績方面最重要的會計政策，以及需要管理層做出最困難、最主觀或最複雜判斷的（「控件」）； (B) 影響關鍵會計政策應用的判斷和不確定因素；以及 (C) 在不同條件下或使用不同假設情況下可能報告不同金額的可能性及其解釋；公司管理層已就所描述在《初步招股說明書》與《招股說明書》中的關鍵會計政策的選擇、應用和披露進行審查並同意，並就該披露徵求了獨立會計師的意見。關鍵會計政策本章描述了在《初步招股說明書》與《招股說明書》中所列關鍵會計政策的選擇、應用和披露事項，並就此事項與其獨立會計師進行了磋商。

3. 增發計劃在承銷商授權 釋放證券後，承銷商打算根據招股說明書中規定的條款和條件向公衆出售證券。

4. 公司的契約公司承認、立約並同意，向承銷商承認、立約並同意：

(a)註冊聲明以及其任何修訂已經生效，如果使用了Rule 430A或者根據Rule 424(b)的規定需要提交招股說明書，則公司將根據Rule 424(b)提交招股說明書（如果使用了Rule 430A，則必須正確填寫）在規定的時間內，並將向承銷商提供有關及時提交的證據。

(b) 在自本日起至最終認購日或者在保薦人律師的合理意見認爲不再需要根據法律交付招股說明書（或者改爲根據法案規定的第173(a)條通知）與承銷商或經銷商進行銷售交易之日爲止，在修改或補充登記聲明書、一般披露文件或招股說明書之前，公司應向承銷商和保薦人律師提供每份擬議的修改或補充草案供審閱，公司不應在交付給保薦人律師後36小時內未經承銷商反對而提交任何該類擬議的修改或補充。術語「一般披露文件」是指在本日或之前發佈的Issuer Free Writing Prospectus(es)（如下所定義）、與本次提供有關的最新初步招股說明書以及附表A所載信息的合集。(C) 任何允許的自由撰寫招股說明書在其發行日、任何銷售時間點和任何在之後的 Prospectus Delivery Period(下面定義)中(除非公司根據5(b)(iii)中描述，通知經紀人在此之前，除外)都不會包含與註冊聲明書、任何基礎招股說明書或招股說明書中包含的信息相沖突的任何信息。對於允許的自由撰寫招股說明書中的描述或省略，限於根據書面信息向公司提供的信息，對於公司明確地要求在其中使用，因此理解並同意，截至本協議日期，只能通過代理有關信息進行提交，其中包括第5(b)(ii)節中描述的信息。在修改或補充登記聲明書、一般披露文件或招股說明書之前，公司應向承銷商和保薦人律師提供每份擬議的修改或補充草案供審閱，公司不應在交付給保薦人律師後36小時內未經承銷商反對而提交任何該類擬議的修改或補充。術語「一般披露文件」是指在本日或之前發佈的Issuer Free Writing Prospectus(es)（如下所定義）、與本次提供有關的最新初步招股說明書以及附表A所載信息的合集。

(c) 在本協議日期之後，公司應及時以書面形式告知承銷商：(i) 接收委員會的任何意見、或對補充信息的要求；(ii) 任何後續有效文件或註冊聲明的修正或補充，普通披露文件或招股說明書的提交時間和日期；(iii) 任何註冊聲明的後續有效修正生效的時間和日期；以及(iv) 委員會發布任何停止訂單以暫停註冊聲明或其後的任何後續有效修正，或禁止或暫停其使用或使用任何招股說明書、普通披露文件、招股說明書或根據規章第433條定義的任何發行人自由書面說明書發行人自由撰寫招股說明書”），或者啓動任何程序，以將股票從證券交易所撤銷、暫停或終止上市，或者威脅要啓動任何此類目的程序。如果委員會在任何時候發佈任何此類暫停令，公司將盡最大努力在最早可能的時刻獲得解除該令。此外，公司同意遵守法案下適用的第424(b)、第430A和第430億條規定，並將盡最大努力確認公司根據第424(b)或第433條規定提交的任何申報已及時被委員會接收（而不依賴於第424(b)(8)或第164(b)條規定）。

(d) (i) 在招股說明書交付期內，公司將在所有重要方面遵守現行生效的法案和隨後修訂的法案，以及隨時生效的相關法規規定的所有要求，以允許按照本文規定、一般披露文件、註冊聲明和招股書繼續銷售或交易證券。如果在該期間發生任何事件或發展，導致招股書（或如果招股書尚未提供給擬購買者，則一般披露文件）包含本文述之事實的不實陳述，或者遺漏在當時情況下爲使該陳述不具誤導性所必要的重要事實；或者在該期間，公司或其律師或承銷商或承銷商的律師認爲有必要或適當來修訂註冊聲明或補充招股書（或如果招股書尚未提供給擬購買者，則一般披露文件）以遵守法案時，公司將及時通知承銷商，並將及時修訂註冊聲明或補充招股書（或如果招股書尚未提供給擬購買者，則一般披露文件），或者提交此類文件（由公司承擔費用），以便糾正該陳述或遺漏或實現該遵守。

(ii) If at any time following the issuance of an Issuer Free Writing Prospectus there occurs an event or development as a result of which such Issuer Free Writing Prospectus would conflict with the information contained in the Registration Statement or the Prospectus or would include an untrue statement of a material fact or would omit to state a material fact necessary in order to make the statements therein, in light of the circumstances there existing, not misleading, the Company will promptly notify the Underwriters and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission.

(e) The Company will deliver to the Underwriters and Underwriters’ Counsel a copy of the Registration Statement, as initially filed, and all amendments thereto, including all consents and exhibits filed therewith, and will maintain in the Company’s files manually signed copies of such documents for at least five (5) years after the date of filing thereof. The Company will promptly deliver to the Underwriters such number of copies of any Preliminary Prospectus, the Prospectus, the Registration Statement, and all amendments of and supplements to such documents, if any, and all documents which are exhibits to the Registration Statement and any Preliminary Prospectus or Prospectus or any amendment thereof or supplement thereto, as the Underwriters may reasonably request. On the Business Day next succeeding the date of this Agreement, and from time to time thereafter, the Company will furnish to the Underwriters’ copies of the Prospectus in such quantities as the Underwriters may reasonably request.

(f) The Company consents to the use and delivery of the Preliminary Prospectus by the Underwriters in accordance with Rule 430 and Section 5(b) of the Act.

(g) If the Company elects to rely on Rule 462(b) under the Act, the Company shall both file a Rule 462(b) Registration Statement with the Commission in compliance with Rule 462(b) by the earlier of: (i) 10:00 P.M., Eastern time, on the date of this Agreement, and (ii) the time that confirmations are given or sent, as specified by Rule 462(b)(2), and pay the applicable fees in accordance with Rule 111 of the Act.

(h) The Company will use its reasonable best efforts, in cooperation with the Underwriters, at or prior to the time of effectiveness of the Registration Statement, to qualify the Securities for offering and sale under the securities laws relating to the Offering or sale of the Securities of such jurisdictions as the Underwriters may reasonably designate and to maintain such qualifications in effect for so long as required for the distribution thereof; except that in no event shall the Company be obligated in connection therewith to qualify as a foreign corporation or to execute a general consent to service of process or to subject itself to taxation if it is otherwise not so subject.

(i) The Company will make generally available (which includes filings pursuant to the Exchange Act made publicly through the Electronic Data Gathering, Analysis and Retrieval (“EDGAR”) system) to its security holders as soon as practicable, but in any event not later than 15 months after the end of the Company’s current fiscal quarter, an earnings statement (which need not be audited) covering a 12-month period that shall satisfy the provisions of Section 11(a) of the Act and Rule 158 of the Regulations.

(j) Except with respect to (i) securities of the Company which may be issued in connection with an acquisition of another entity (or the assets thereof), (ii) the issuance of securities of the Company intended to provide the Company with proceeds to acquire another entity (or the assets thereof), or (iii) the issuance of securities under the Company’s stock option plans with exercise or conversion prices at fair market value (as defined in such plans) in effect from time to time, during the three (3) months following the Closing Date, the Company or any successor to the Company shall not undertake any public or private offerings of any equity securities of the Company (including equity-linked securities) without the prior written consent of the Underwriters, which consent shall not be unreasonably withheld, delayed or conditioned.

(k) Following the Closing Date, any of the entities and individuals listed on Schedule B hereto (the “Lock-Up Parties”), without the prior written consent of the Underwriters, shall not sell or otherwise dispose of any securities of the Company, whether publicly or in a private placement, during the period that their respective lock-up agreements are in effect. The Company will deliver to the Underwriters the agreements of the Lock-Up Parties to the foregoing effect prior to the Closing Date, which agreements shall be substantially in the form attached hereto as Annex I.

(l) The Company will not issue press releases or engage in any other publicity without the Underwriter’s prior written consent, for a period ending at 5:00 P.M., Eastern time, on the first Business Day following the twenty-fifth (25th) day following the Closing Date, other than normal and customary releases issued in the ordinary course of the Company’s business, or as required by law.

(m) The Company will apply the net proceeds from the sale of the Securities as set forth under the caption “Use of Proceeds” in the Prospectus. Without the prior written consent of the Underwriters, except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, no proceeds of the Offering will be used to pay outstanding loans from officers, directors or shareholders or to pay any accrued salaries or bonuses to any employees or former employees.

(n) The Company will use its reasonable best efforts to effect and maintain the listing of the Ordinary Shares on the NASDAQ Capital Market for at least two (2) years after the Effective Date, unless such listing is terminated as a result of a transaction approved by the holders of a majority of the voting securities of the Company. If the Company fails to maintain such listing of its Shares on the NASDAQ Capital Market or other Trading Market, for a period of two (2) years from the Effective Date, the Company, at its expense, shall obtain and keep current a listing of such securities in the Standard & Poor’s Corporation Records Services or Mergent’s Industrial Manual; provided that Mergent’s OTC Industrial Manual is not sufficient for these purposes. “Trading Market” means any of the following markets or exchanges on which the Ordinary Shares is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Stock Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any of the foregoing).

(o) The Company will use its reasonable best efforts to do and perform all things required to be done or performed under this Agreement by the Company prior to the Closing Date, and to satisfy all conditions precedent to the delivery of the Securities.

(p) The Company will not take, and will cause its Affiliates not to take, directly or indirectly, any action which constitutes or is designed to cause or result in, or which could reasonably be expected to constitute, cause or result in, the stabilization or manipulation of the price of any security to facilitate the sale or resale of any of the Securities.

(q) The Company shall cause to be prepared and delivered to the Underwriters, at its expense, within two (2) Business Days from the date of this Agreement, an Electronic Prospectus to be used by the Underwriters in connection with the Offering. As used herein, the term “Electronic Prospectus” means a form of prospectus, and any amendment or supplement thereto, that meets each of the following conditions: (i) it shall be encoded in an electronic format, satisfactory to the Underwriters, that may be transmitted electronically by the Underwriters to offerees and purchasers of the Securities for at least the period during which a Prospectus relating to the Securities is required to be delivered under the Act or the Exchange Act; (ii) it shall disclose the same information as the paper prospectus and prospectus filed pursuant to EDGAR, except to the extent that graphic and image material cannot be disseminated electronically, in which case such graphic and image material shall be replaced in the electronic prospectus with a fair and accurate narrative description or tabular representation of such material, as appropriate; and (iii) it shall be in or convertible into a paper format or an electronic format, satisfactory to the Underwriters, that will allow recipients thereof to store and have continuously ready access to the prospectus at any future time, without charge to such recipients (other than any fee charged for subscription to the Internet as a whole and for online time).

5. Representations and Warranties of the Underwriters.

The Underwriters represents and agrees that, unless it obtains the prior written consent of the Company, it has not made and will not make any offer relating to the Securities that would constitute a “free writing prospectus,” as defined in Rule 405 under the Act, required to be filed with the Commission; provided that the prior written consent of the parties hereto shall be deemed to have been given in respect of the free writing prospectuses included on Schedule C. Any such free writing prospectus consented to by the Underwriters is herein referred to as a “Permitted Free Writing Prospectus.” The Underwriters represents that it has treated or agrees that it will treat each Permitted Free Writing Prospectus as an “issuer free writing prospectus,” as defined in Rule 433, and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely Commission filing where required, legending and record keeping.

6. Consideration; Payment of Expenses.

(a) In consideration of the services to be provided for hereunder, the Company shall pay to the Underwriters or its designee(s) the following compensation (or pro rata portion thereof, if applicable) with respect to the Securities purchased from the Company in this Offering:

(i) an underwriting discount equal to seven percent (7.0%) of the aggregate gross proceeds (inclusive of the Over-allotment Option to purchase the Additional Shares);

(ii) a non-accountable expense allowance of one percent (1.0%) of the gross proceeds of the Offering;

(iii) an accountable expense allowance of up to US$150,000, of which US$55,000 has already been paid to the Underwriters as an advance against accountable expenses; and

(iv) an advisory fee of $70,000, of which $30,000 has already been paid to the Underwriters, and the remaining $40,000 will be paid to the Underwriters within 3 business days of the Company’s listing.

(b) intentionally omitted.

(c) The Underwriters reserves the right to reduce any item of compensation or adjust the terms thereof as specified herein in the event that a determination shall be made by FINRA to the effect that the Underwriters’ aggregate compensation is in excess of FINRA Rules or that the terms thereof require adjustment.

(d) Whether or not the transactions contemplated by this Agreement, the Registration Statement and the Prospectus are consummated or this Agreement is terminated, the Company hereby agrees to pay all costs and expenses incident to the Offering, including the following:

(i) all expenses in connection with the preparation, printing, formatting for EDGAR and filing of the Registration Statement, any Preliminary Prospectus and the Prospectus and any and all amendments and supplements thereto and the mailing and delivering of copies thereof to the Underwriters and dealers;

(ii) all filing fees in connection with filings with FINRA’s Public Offering System;

(iii) all fees, disbursements and expenses of the Company’s counsel and accountants in connection with the registration of the Securities under the Act and the Offering and with the qualifications of the Securities for offering and sale under state or foreign securities or blue sky laws, if necessary;

(iv) all reasonable fees associated with translation services (if necessary);

(v) all fees and expenses in connection with listing the Securities on a national securities exchange;

(vi) all fees and expenses in connection with pre-approved due diligence work in legal, finance, and business;

(vii) all the road show expenses incurred by the Company; and

 (viii) the cost and charges of any transfer agent or registrar for the Securities.

(e) 但是，除非本協議另有規定，否則由承銷商支付所有自身的費用和開支。 第6節和本協議的第8條, 9和頁面。11(d) 在此，承銷商將支付所有自己的費用和支出。儘管在本協議中與其相反的任何規定， 第6節，如果根據本協議終止協議， 法案第12(b)節： 根據本協議或任何重大不利變化之前或之後，公司將支付截至該日期發生的未報銷費用，減去先前支付的任何預付款（「 預付款」）。所有文件化的實際費用和主承銷商的諮詢費用（包括但不限於主承銷商律師費和合理可覈算的差旅費），就本協議而言，應當限制爲根據 FINRA 規則 5110 允許的實際發生費用。在任何情況下，公司應報銷的此類費用和費用總額不得超過 150,000 美元，其中包括預付款。在主承銷商的文件化實際費用和諮詢費用低於預付款的情況下，主承銷商將根據 FINRA 規則 5110(g)(4)(A) 和 5110(g)(4)(B)返還未被實際費用抵消的預付款部分給公司。

7. 承銷商義務條件承銷商購買和支付本函規定的股份的義務應受以下條件約束：（i）公司在此所含陳述和保證的準確性，即截至本文件日期和結算日期時的準確性，（ii）向承銷商或承銷商代理提供的任何證 第7節。受限制的股票和受限制的股票單位。 的任何錯誤或遺漏，(iii) 公司在此履行其義務，並且(iv) 必須滿足以下每項附加條件。 按照本 第7節。受限制的股票和受限制的股票單位。，術語「交易截止日期」和「交割」將指公司股份的交易截止日期，且前述和後續條件必須於每次交割時得到滿足。

(a)註冊聲明應在本協議日期當天最遲下午5:30生效，並且所有必要的監管和上市批准應已獲得，或者如承銷商書面同意的較晚時間和日期。如果公司選擇依賴《法案》第430A條規定，那麼招股說明書應按照其條款及時向委員會提交，並且招股說明書的格式應包含有關證券描述、分配方式以及類似事項的信息，並根據第424(b)條規定向委員會提交; 在結算日期和實際結算時間之前，註冊聲明或其任何部分的生效均未受到停止訂單的暫停，或其任何修訂，也未受到暫停或阻止一般披露文件、招股說明書或任何發行人自由書面招股說明書的使用; 未頒佈任何暫停生效註冊聲明的命令，也未針對此類命令的發出或威脅; 對於委員會要求的所有額外信息（應包括在註冊聲明、一般披露文件、招股說明書、任何發行人自由書面招股說明書中或其他地方），均已按照承銷商的滿意程度加以滿足。

(b) 保薦人應合理確定並告知公司，認爲註冊聲明、一般披露文件或招股說明書，或其任何修訂或補充，或任何發行人自由撰寫招股說明書，包含在其合理看法中屬實而在保薦人合理看法中屬實但在其中必須進行陳述或有必要使其中的陳述不誤導的事實。

(c) 承銷商應收到法律意見書，形式和內容應合承銷商及承銷商律師合理滿意，內容包括 (i) 日期爲收盤日的，致公司，並抄送承銷商的開曼群島代表律師 Appleby 的意見書; (ii) 日期爲收盤日的，致承銷商並抄送承銷商的美國法律代表 Hunter Taubman Fischer &Li LLC 的公司美國法律顧問的意見書; (iii) 日期爲收盤日的，致公司的，與 Broad & Bright 合作的香港法律顧問 CFN Lawyers 的意見書; 以及 (iv) 日期爲收盤日的，僅致公司的中國法律顧問 Commerce & Finance Law Offices 的意見書。

(d) 承銷商應收到公司首席執行官和財務主管出具的證書，日期爲每個結算日和任何行權結算日，證明：(i) 本子第 (a) 小節所列條件已得到滿足。 第7節。受限制的股票和受限制的股票單位。 ，(ii) 截至本協議日期、每個結算日和任何行權結算日，公司在本協議中所陳述的聲明和保證是準確的。 第2節 ，(iii) 每個結算日和任何行權結算日，公司根據本協議要履行或遵守的所有協議、條件和義務已經得到妥善履行或遵守，(iv) 沒有停止令暫停註冊聲明或其任何修訂生效，且未由委員會發出任何暫停註冊聲明生效的停止令或發起或威脅採取相關程序，(v) 沒有需要根據法規納入註冊聲明及招股說明書中的任何調整或調整後基本財務報表未包括在內，並且，(vi) 自注冊聲明及招股說明書所載資料之日期後，公司未發生任何重大不利變化或任何涉及前景重大不利變化的事項，無論是否源自業務常規交易。

在每個結束日期和任何選擇性結束日期，承銷商應收到由公司授權的執行官簽署的日期爲結束日期和任何選擇性結束日期的公司證書，證明：(i)每份公司章程和公司規約均真實完整，未經修改，且有效；(ii)涉及本次發行的公司董事會決議均有效，且未經修改；(iii)公司的合法地位；以及(iv)公司執行官的任期。該證書中提及的文件應附在證書中。

（f）在本協議日期及交割日，承銷商應分別於該等日期收到WWC的「安慰」函，該函應致信承銷商，形式和內容應令承銷商和承銷商的法律顧問滿意，確認他們對公司具有《法案》和所有適用法規所規定的獨立註冊會計師的身份，並說明截至該等日期的財務信息以及與登記聲明有關的其他事項的結論和發現（或者就指定財務信息所載的日期以來涉及變動或發展的事項而言，就不晚於該日期之前五（5）天內的日期）。

(g) 在簽署並交付本協議之後，但在截止日期或期權截止日期之前，或者在註冊聲明中提供信息的日期（不包括任何修訂）和招股說明書（不包括其中任何補充）之前，該公司的股本或長期債務、業務、狀況（包括財務或其他狀況）、經營業績、股東權益或整體財產等方面未發生任何變化或發展，無論是與業務日常經營中的交易有關或非業務常識的發展，包括但不限於出現火災、洪水、風暴、爆炸、事故、戰爭或恐怖主義行爲或其他災害等情況，這些情況中任何一種，對於承銷商來說，如果其合理判斷是如此重大和不利，以至於使得按照本協議預期進行證券或發行銷售變得不切實際或不明智。

(h)承銷商應當收到鎖定協議，由各方鎖定方簽署，每個鎖定方簽署，情況均基本符合附件所附形式 附件I.

(i) The Ordinary Shares are registered under the Exchange Act and, as of the Closing Date, the Shares shall be listed and admitted and authorized for trading on the NASDAQ Capital Market and satisfactory evidence of such action shall have been provided to the Underwriters. The Company shall have taken no action designed to terminate, or likely to have the effect of terminating, the registration of the Shares under the Exchange Act or delisting or suspending the Shares from trading on the NASDAQ Capital Market, nor will the Company have received any information suggesting that the Commission or the NASDAQ Capital Market is contemplating terminating such registration or listing. The Firm Shares and the Additional Shares shall be DTC eligible.

(j) FINRA shall have confirmed that it has not raised any objection with respect to the fairness and reasonableness of the underwriting terms and arrangements.

(k) No action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely affect or potentially materially and adversely affect the business or operations of the Company.

(l) The Company shall have furnished the Underwriters and Underwriters’ Counsel with such other certificates, opinions or documents as they may have reasonably requested.

8. Indemnification.

(a) To the fullest extent permitted under applicable law, the Company agrees to indemnify and hold harmless the Underwriters and each Person, if any, who controls the Underwriters within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, against any losses, liabilities, claims, damages and expenses whatsoever, as incurred (including but not limited to reasonable attorneys’ fees and any and all reasonable expenses whatsoever, incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, and any and all amounts paid in settlement of any claim or litigation), joint or several, to which they or any of them may become subject under the Act, the Exchange Act or otherwise (including in settlement of any litigation if such settlement is effected with the written consent of the Company), insofar as such losses, liabilities, claims, damages or expenses (or actions in respect thereof) arise out of or are based upon: (i) an untrue statement or alleged untrue statement of a material fact contained in (A) the Registration Statement, including the information deemed to be a part of the Registration Statement at the time of effectiveness and at any subsequent time pursuant to Rules 430A and 430B of the Regulations, any Preliminary Prospectus, the General Disclosure Package, the Prospectus, or any amendment or supplement to any of them or (B) any Issuer Free Writing Prospectus or any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Securities (“Marketing Materials”), including any road show or investor presentations made to investors by the Company (whether in person or electronically), or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading and will reimburse such indemnified party for any legal or other expenses reasonably incurred by it in connection with investigations or defending against such losses, liabilities, claims, damages or expenses (or actions in respect thereof); or (ii) in whole or in part upon any inaccuracy in the representations and warranties of the Company contained herein; or (iii) in whole or in part upon any failure of the Company to perform its obligations hereunder; provided, however, that the Company shall not be liable in any such case to the extent that any such loss, liability, claim, damage or expense (or action in respect thereof) arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, any Preliminary Prospectus, the General Disclosure Package, the Prospectus, or any such amendment or supplement to any of them, or any Issuer Free Writing Prospectus or any Marketing Materials in reliance upon and in conformity with the Underwriters’ Information.

(b) To the fullest extent permitted under applicable law, the Underwriters agrees to indemnify and hold harmless the Company, each of the directors of the Company, each of the officers of the Company who shall have signed the Registration Statement, and each other Person, if any, who controls the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, against any losses, liabilities, claims, damages and expenses whatsoever, as incurred (including but not limited to reasonable attorneys’ fees and any and all reasonable expenses whatsoever, incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, and any and all amounts paid in settlement of any claim or litigation), joint or several, to which they or any of them may become subject under the Act, the Exchange Act or otherwise (including in settlement of any litigation if such settlement is effected with the written consent of the Underwriters), insofar as such losses, liabilities, claims, damages or expenses (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, at the time of effectiveness and at any subsequent time pursuant to Rules 430A and 430B of the Regulations, any Preliminary Prospectus, the General Disclosure Package, the Prospectus, any amendment or supplement to any of them or any Marketing Materials, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse such indemnified party for any legal or other expenses reasonably incurred by it in connection with investigating or defending against such losses, liabilities, claims, damages or expenses (or actions in respect thereof), in each case to the extent, but only to the extent, that any such loss, liability, claim, damage or expense (or action in respect thereof) arises out of or is based upon any such untrue statement or alleged untrue statement or omission or alleged omission made in the Underwriters’ Information.

(c) Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice of any claim or the commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection, notify each party against whom indemnification is to be sought in writing thereof (but the failure so to notify an indemnifying party shall not relieve the indemnifying party from any liability which it may have under this Section 8 to the extent that it is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability that such indemnifying party may have otherwise than on account of the indemnity agreement hereunder). In case any such claim or action is brought against any indemnified party, and it so notifies an indemnifying party thereof, the indemnifying party will be entitled to participate at its own expense in the defense of such action, and to the extent it may elect by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from such indemnified party, to assume the defense thereof with counsel satisfactory to such indemnified party; provided however, that counsel to the indemnifying party shall not (except with the written consent of the indemnified party) also be counsel to the indemnified party. Notwithstanding the foregoing, the indemnified party or parties shall have the right to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such indemnified party or parties unless: (i) the employment of such counsel shall have been authorized in writing by one of the indemnifying parties in connection with the defense of such action; (ii) the indemnifying parties shall not have employed counsel to have charge of the defense of such action within a reasonable time after notice of the claim or the commencement of the action; (iii) the indemnifying party does not diligently defend the action after assumption of the defense; or (iv) such indemnified party or parties shall have reasonably concluded that a conflict may arise between the positions of the indemnifying party and the indemnified party, or any of them, in conducting the defense of any such action or there may be legal defenses available to it or them which are different from or additional to those available to any of the indemnifying parties (in which case the indemnifying parties shall not have the right to direct the defense of such action on behalf of the indemnified party or parties), in any of which events such fees and expenses shall be borne by the indemnifying parties and shall be paid as incurred. It is understood that the indemnifying party shall not, in respect of the legal expenses of any indemnified party in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) of the indemnified party or parties unless such separate representations are required under applicable ethics rules that govern the representations of the indemnified party or parties by such legal counsel. In the case of any separate firm for the Underwriters and such control persons and affiliates of any Underwriters, such firm shall be designated in writing by the Underwriters. In the case of more than one separate firm (in addition to any local counsel) for the Company, and such directors, officers and control persons of the Company, such firm shall be designated in writing by the Company. No indemnifying party shall, without the prior written consent of the indemnified parties, effect any settlement or compromise of, or consent to the entry of judgment with respect to, any pending or threatened claim, investigation, action or proceeding in respect of which indemnity or contribution may be or could have been sought by an indemnified party under this Section 8 or Section 9 hereof (whether or not the indemnified party is an actual or potential party thereto), unless (x) such settlement, compromise or judgment (i) includes an unconditional release of the indemnified party from all liability arising out of such claim, investigation, action or proceeding and (ii) does not include a statement as to or an admission of fault, culpability or any failure to act, by or on behalf of the indemnified party, and (y) the indemnifying party confirms in writing its indemnification obligations hereunder with respect to such settlement, compromise or judgment.

9. Contribution. In order to provide for contribution in circumstances in which the indemnification provided for in Section 8 is for any reason held to be unavailable from any indemnifying party or is insufficient to hold harmless a party indemnified thereunder, the Company and the Underwriters shall contribute to the aggregate losses, claims, damages, liabilities and expenses of the nature contemplated by such indemnification provision (including any investigation, legal and other expenses incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claims asserted, but after deducting in the case of losses, claims, damages, liabilities and expenses suffered by the Company, any contribution received by the Company from Persons, other than the Underwriters, who may also be liable for contribution, including Persons who control the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, officers of the Company who signed the Registration Statement and directors of the Company), as incurred, to which the Company and one or more of the Underwriters may be subject, in such proportions as is appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other hand from the Offering and sale of the Securities or, if such allocation is not permitted by applicable law, in such proportions as are appropriate to reflect not only the relative benefits referred to above but also the relative fault of the Company and the Underwriters in connection with the statements or omissions which resulted in such losses, claims, damages, liabilities or expenses, as well as any other relevant equitable considerations. The relative benefits received by the Company and the Underwriters shall be deemed to be in the same proportion as (x) the total proceeds from the Offering (net of underwriting discount and commission but before deducting expenses) received by the Company bears to (y) the underwriting discount and commissions received by the Underwriters, in each case as set forth in the table on the cover page of the Prospectus. The relative fault of the Company and the Underwriters shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section 9 were determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section 9. The aggregate amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred to above in this Section 9 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in investigating, preparing or defending against any litigation, or any investigation or proceeding by any judicial, regulatory or other legal or governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission or alleged omission. Notwithstanding the provisions of this Section 9: (i) no Underwriters shall be required to contribute any amount in excess of the underwriting discounts applicable to the Securities underwritten by it and distributed to the public and (ii) no Person guilty of fraudulent misrepresentation (within the meaning of Section 12(f) of the Act) shall be entitled to contribution from any Person who was not guilty of fraudulent misrepresentation (within the meaning of Section 12(f) of the Act). For purposes of this Section 9, each Person, if any, who controls an Underwriter within the meaning of Section 15 of the Act or Section 20 of the Exchange Act shall have the same rights to contribution as such Underwriter, and each Person, if any, who controls the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act, each officer of the Company who shall have signed the Registration Statement and each director of the Company shall have the same rights to contribution as the Company, subject in each case to clauses (i) and (ii) of the immediately preceding sentence. Any party entitled to contribution will, promptly after receipt of notice of commencement of any action, suit or proceeding against such party in respect of which a claim for contribution may be made against another party or parties, notify each party or parties from whom contribution may be sought, but the omission to so notify such party or parties shall not relieve the party or parties from whom contribution may be sought from any obligation it or they may have under this Section 9 or otherwise. As used herein, a “Person” refers to an individual or entity.

10. Survival of Representations and Agreements. All representations, warranties, covenants and agreements of the Company and the Underwriters contained in this Agreement or in certificates of officers of the Company submitted pursuant hereto, including, without limitation, the agreements contained in Sections 6, 14 and 15, the indemnity agreements contained in Section 8 and the contribution agreements contained in Section 9, shall remain operative and in full force and effect regardless of any investigation made by or on behalf of the Underwriters or any controlling Person thereof or by or on behalf of the Company, any of its officers or directors or any controlling Person thereof, and shall survive delivery of and payment for the Securities to and by the Underwriters. The representations and warranties contained in Section 2 and Section 5 and the covenants and agreements contained in Sections 4, 6, 8, 9, 14 and 15 shall survive any termination of this Agreement, including termination pursuant to Section 12 and Section 16. For the avoidance of doubt, in the event of termination the Underwriters will receive only documented out-of-pocket accountable expenses and advisory fee actually incurred subject to the limit in Section 12(d) below, in compliance with FINRA Rules 5110.

11. Right of First Refusal. The Company and the Underwriters agree that for a period of twelve (12) months from the Closing Date, whether or not the engagement contemplated under this Agreement is terminated (other than termination for Cause, as defined below), the Company grants Revere Securities LLC (“Revere”) the right (provided the Offering is completed) to provide investment banking services to the Company on an exclusive basis in all matters for which investment banking services are sought by the Company (such right, the “Right of First Refusal”), which right is exercisable in the Revere’s sole discretion. For these purposes, investment banking services shall include, without limitation, (a) acting as lead manager for any underwritten public offering; (b) acting as exclusive placement agent, initial purchaser or financial advisor in connection with any private offering of securities of the Company; and (c) acting as financial advisor in connection with any sale or other transfer by the Company, directly or indirectly, of a majority or controlling portion of its capital stock or assets to another entity, any purchase or other transfer by another entity, directly or indirectly, of a majority or controlling portion of the capital stock or assets of the Company, and any merger or consolidation of the Company with another entity. Revere shall notify the Company of its intention to exercise the Right of First Refusal within 15 business days following notice in writing by the Company. Any decision by Revere to act in any such capacity shall be contained in separate agreements, which agreements would contain, among other matters, provisions for customary fees for transactions of similar size and nature, as may be mutually agreed upon, and indemnification of Revere and shall be subject to general market conditions. If Revere declines to exercise the Right of First Refusal or the Company does not receive any response from Revere within the aforesaid 15 business day-period, the Company shall have the right to retain any other person or persons to provide such services on terms and conditions which are not more favorable to such other person or persons than the terms declined by Revere. The Right of First Refusal granted hereunder may be terminated by the Company for “Cause,” which shall mean a material breach by Revere of the engagement letter.

12. Effective Date of Agreement; Termination.

(a) This Agreement shall become effective upon the later of: (i) receipt by the Underwriters and the Company of notification of the effectiveness of the Registration Statement or (ii) the execution of this Agreement by all parties hereto. Notwithstanding any termination of this Agreement, the provisions of this Section 12 and of Sections 1, 4, 6, 8, 9, 14 and 15 shall remain in full force and effect at all times after the execution hereof to the extent they are in compliance with FINRA Rule 5110.

(b) The Underwriters shall have the right to terminate this Agreement at any time prior to the consummation of the Closing if: (i) any domestic or international event or act or occurrence has materially disrupted, or in the reasonable opinion of the Underwriters will in the immediate future materially disrupt, the market for the Company’s securities or securities in general; or (ii) trading on the New York Stock Exchange or the NASDAQ Stock Market has been suspended or made subject to material limitations, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices for securities have been required, on the NYSE Euronext or the NASDAQ Stock Market or by order of the Commission, FINRA or any other governmental authority having jurisdiction; or (iii) a banking moratorium has been declared by any state or federal authority or any material disruption in commercial banking or securities settlement or clearance services has occurred; or (iv) (A) there has occurred any outbreak or escalation of hostilities or acts of terrorism involving the United States, Hong Kong, BVI, the Cayman islands or there is a declaration of a national emergency or war by the United States Hong Kong, BVI, or the Cayman islands or (B) there has been any other calamity or crisis or any change in political, financial or economic conditions, if the effect of any such event in (A) or (B), in the reasonable judgment of the Underwriters, is so material and adverse that such event makes it impracticable or inadvisable to proceed with the offering, sale and delivery of the Firm Shares on the terms and in the manner contemplated by the Prospectus.

(c) Any notice of termination pursuant to this Section 12 shall be in writing and delivered in accordance with Section 13.

(d) If this Agreement shall be terminated pursuant to any of the provisions hereof (other than pursuant to Section 12(b) hereof), or if the sale of the Securities provided for herein is not consummated because any condition to the obligations of the Underwriters set forth herein is not satisfied or because of any refusal, inability or failure on the part of the Company to perform any agreement herein or comply with any provision hereof, the Company will, subject to demand by the Underwriters, reimburse the Underwriters for only those documented out-of-pocket expenses and advisory fee (including the reasonable fees and expenses of their counsel), actually incurred by the Underwriters in connection herewith as allowed under FINRA Rule 5110 less any amounts previously paid by the Company); provided, however, that all such expenses and fees, including the costs and expenses and fees set forth in Section 6(d) which were actually paid, shall not exceed US$150,000 in the aggregate, including any advances.

13. Notices. All communications hereunder, except as may be otherwise specifically provided herein, shall be in writing, and:

(a) if sent to the Underwriters, shall be mailed, delivered, or emailed, to:

Cathay Securities, Inc.

40 Wall Street, Suite 3600

New York, NY 10005

Attention: Xiaoyu Li, CEO & Head of Investment Banking

Email: Shell.Li@cathaysecurities.com

with a copy to Underwriters’ Counsel at:

Ortoli Rosenstadt LLP

366 Madison Avenue, 3rd Floor

New York, NY 10017

Attention: Mengyi “Jason” Ye, Esq.

Email: jye@orllp.legal

(b) if sent to the Company, shall be mailed, delivered, or emailed, to:

Samfine Creation Holdings Group Limited

Flat B, 8/F, Block 4 Kwun Tong Industrial Centre

436-446 Kwun Tong Road

Kwun Tong, Hong Kong

Attention: Wayne, Wing Wah Cheng, CEO

Email: 111@1398.cn

with a copy (which shall not constitute notice) to:

Hunter Taubman Fischer & Li LLC

950 Third Avenue, 19th Floor

New York, NY 10022

Attn: Ying Li, Esq. and Guillaume de Sampigny, Esq.

Email: yli@htflawyers.com and gdesampigny@htflawyers.com

14. Parties; Limitation of Relationship. This Agreement shall inure solely to the benefit of, and shall be binding upon, the Underwriters, the Company and the controlling Persons, directors, officers, employees and agents referred to in Sections 8 and 9 hereof, and their respective successors and assigns, and no other Person shall have or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Agreement or any provision herein contained. This Agreement and all conditions and provisions hereof are intended to be for the sole and exclusive benefit of the parties hereto and such Persons and their respective successors and assigns, and not for the benefit of any other Person. The term “successors and assigns” shall not include a purchaser, in its capacity as such, of Securities from the Underwriters.

15. Governing Law. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to the conflict of laws principles thereof. Each of the parties hereto hereby submits to the exclusive jurisdiction of the federal and state courts in the Borough of Manhattan in The City of New York (each, a “New York Court”) in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby. Each of the parties hereto irrevocably waives any objection to the laying of venue of any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby in the New York Courts, and irrevocably waives and agrees not to plead or claim in any such court that any such suit or proceeding in any such court has been brought in an inconvenient forum. The Company irrevocably appoints Cogency Global Inc., 122 East 42nd St 18th Floor, New York, NY 10168 as its authorized agent (the “Authorized Agent”) in the Borough of Manhattan in The City of New York upon which process may be served in any such suit or proceeding, and agrees that service of process in any manner permitted by applicable law upon such agent shall be deemed in every respect effective service of process in any manner permitted by applicable law upon the Company in any such suit or proceeding. The Company further agrees to take any and all actions as may be necessary to maintain such designation and appointment of such agent in full force and effect for a period of three years from the date of this Agreement.

16. Default of Underwriters. If any Underwriter or Underwriters default in their obligations to purchase Securities hereunder on either the Closing Date or any Option Closing Date and the aggregate number of Securities that such defaulting Underwriter or Underwriters agreed but failed to purchase does not exceed 10% of the total number of Securities that the Underwriters are obligated to purchase on such Closing Date or Option Closing Date, the Representative may make arrangements satisfactory to the Company for the purchase of such Securities by other persons, including any of the Underwriters, but if no such arrangements are made by such Closing Date or Option Closing Date, the non-defaulting Underwriters shall be obligated severally, in proportion to their respective commitments hereunder, to purchase the Offered Securities that such defaulting Underwriters agreed but failed to purchase on such Closing Date or Option Closing Date. If any Underwriter or Underwriters so default and the aggregate number of Securities with respect to which such default or defaults occur exceeds 10% of the total number of Securities that the Underwriters are obligated to purchase on such Closing Date or Option Closing Date and arrangements satisfactory to the Representative and the Company for the purchase of such Securities by other persons are not made within 36 hours after such default, this Agreement will terminate without liability on the part of any non-defaulting Underwriter or the Company, except as provided in Section 10. As used in this Agreement, the term “Underwriter” includes any person substituted for an Underwriter under this Section. Nothing herein will relieve a defaulting Underwriter from liability for its default.

17. Entire Agreement. This Agreement, together with the schedules and annexes attached hereto and as the same may be amended from time to time in accordance with the terms hereof, contains the entire agreement among the parties hereto relating to the subject matter hereof and there are no other or further agreements outstanding not specifically mentioned herein. This Agreement supersedes any prior agreements or understandings among or between the parties hereto.

18. Severability. If any term or provision of this Agreement or the performance thereof shall be invalid or unenforceable to any extent, such invalidity or unenforceability shall not affect or render invalid or unenforceable any other provision of this Agreement and this Agreement shall be valid and enforceable to the fullest extent permitted by law.

19. Amendment. This Agreement may only be amended by a written instrument executed by each of the parties hereto.

20. Waiver, etc. The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Agreement or any provision hereof or the right of any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver may be sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.

21. No Fiduciary Relationship. The Company hereby acknowledges that the Underwriters are acting solely as Underwriters in connection with the offering of the Company’s Securities. The Company further acknowledges that the Underwriters is acting pursuant to a contractual relationship created solely by this Agreement entered into on an arm’s-length basis and in no event do the parties intend that the Underwriters act or be responsible as a fiduciary to the Company, its management, shareholders, creditors or any other person in connection with any activity that the Underwriters may undertake or have undertaken in furtherance of the offering of the Company’s Securities, either before or after the date hereof. The Underwriters hereby expressly disclaims any fiduciary or similar obligations to the Company, either in connection with the transactions contemplated by this Agreement or any matters leading up to such transactions, and the Company hereby confirms its understanding and agreement to that effect. The Company hereby further confirms its understanding that the Underwriters has not assumed an advisory or fiduciary responsibility in favor of the Company with respect to the Offering contemplated hereby or the process leading thereto, including, without limitation, any negotiation related to the pricing of the Securities; and the Company has consulted its own legal and financial advisors to the extent it has deemed appropriate in connection with this Agreement and the Offering. The Company and the Underwriters agree that they are each responsible for making their own independent judgments with respect to any such transactions, and that any opinions or views expressed by the Underwriters to the Company regarding such transactions, including but not limited to any opinions or views with respect to the price or market for the Company’s securities, do not constitute advice or recommendations to the Company. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any breach or alleged breach of any fiduciary or similar duty to the Company in connection with the transactions contemplated by this Agreement or any matters leading up to such transactions.

22. Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, and all such counterparts shall together constitute one and the same instrument. Delivery of a signed counterpart of this Agreement by facsimile or other electronic transmission shall constitute valid and sufficient delivery thereof.

23. Headings. The headings herein are inserted for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of, this Agreement.

24. Time is of the Essence. Time shall be of the essence of this Agreement. As used herein, the term “Business Day” shall mean any day other than a Saturday, Sunday or any day on which any of the major U.S. stock exchanges are not open for business.

[Signature Page Follows]

If the foregoing correctly sets forth your understanding, please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement among us.

Confirmed as of the date first written above, on behalf of itself and as Representative of the several Underwriters named on Schedule A hereto:

Cathay Securities, Inc.

[Signature Page to Underwriting Agreement]

SCHEDULE A

Number of Firm Shares: 2,000,000

Public Offering Price per Firm Share: $4.00

Underwriting Discount per Firm Share: $0.28

Non-accountable Expense Allowance per Firm Share: $0.04

SCHEDULE B

Lock-Up Parties 

SCHEDULE C

Free Writing Prospectuses

Two Free Writing Prospectuses filed with the SEC on June 28, 2024 and August 15, 2024 respectively:

https://www.sec.gov/Archives/edgar/data/1926792/000121390024057103/ea0208623-fwp_samfine.htm

https://www.sec.gov/Archives/edgar/data/1926792/000121390024069666/ea0211405-fwp_samfin.htm

Annex I

Lock-Up Agreement

October 14, 2024

Cathay Securities, Inc.

40 Wall Street, Suite 3600

NY, NY 10005 USA

as Representative of the several Underwriters named on Schedule A

to the Underwriting Agreement

Ladies and Gentlemen:

The undersigned understands that Cathay Securities, Inc. (the “Representative”) proposes to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Samfine Creation Holdings Group Limited, an exempted company incorporated in the Cayman Islands (the “Company”), providing for the initial public offering in the United States (the “Initial Public Offering”) of a certain number of the Company’s Ordinary Shares, par value US$0.0000625 per share (the “Ordinary Shares” or the “Securities”). For purposes of this letter agreement, “Shares” shall mean shares of the Company’s Ordinary Shares.

To induce the Underwriters (as defined in the Underwriting Agreement) to continue their efforts in connection with the Public Offering, the undersigned hereby agrees that, without the prior written consent of the Representative, the undersigned will not, during the period commencing on the date hereof and ending six (6) months from the date of commencement of sales of the Initial Public Offering (the “Lock-Up Period”), (1) offer, pledge, announce the intention to sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, make any short sale, or otherwise transfer or dispose of, directly or indirectly, any Shares or any securities convertible into or exercisable or exchangeable for or represent the right to receive Shares, whether now owned or hereafter acquired by the undersigned (collectively, the “Lock-Up Securities”); (2) enter into any swap or other agreement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction described in clause (1) above or this clause (2) is to be settled by delivery of Shares or such other securities, in cash or otherwise; (3) make any written demand for or exercise any right with respect to the registration of any Shares or any security convertible into or exercisable or exchangeable for Shares; or (4) publicly disclose the intention to do any of the foregoing.

Notwithstanding the foregoing, and subject to the conditions below, the undersigned may transfer Lock-Up Securities without the prior written consent of the Representative in connection with (a) transactions relating to Lock-Up Securities acquired in open market transactions after the completion of the Initial Public Offering; (b) transfers of Lock-Up Securities as a bona fide gift, by will or intestacy or to a family member or trust for the benefit of the undersigned and/or one or more family members (for purposes of this lock-up agreement, “family member” means any relationship by blood, marriage or adoption, not more remote than first cousin); (c) transfers of Lock-Up Securities to a charity or educational institution or other not-for-profit organization; (d) if the undersigned, directly or indirectly, controls a corporation, partnership, limited liability company or other business entity, any transfers of Lock-Up Securities to any such corporation, partnership, limited liability company or other business entity, or any shareholder, partner or member of, or owner of similar equity interests in, the same, as the case may be; (e) a sale or surrender to the Company of any options or Shares of the Company underlying options in order to pay the exercise price or taxes associated with the exercise of options or (f) transfers or distributions pursuant to any bona fide third-party tender offer, merger, acquisition, consolidation or other similar transaction made to all holders of the Company’s Shares involving a Change of Control of the Company, provided that in the event that such tender offer, merger, acquisition, consolidation or other such transaction is not completed, the Lock-Up Securities held by the undersigned shall remain subject to the provisions of this lock-up agreement; provided that in the case of any transfer pursuant to the foregoing clauses (b), (c) or (d), (i) any such transfer shall not involve a disposition for value, (ii) each transferee shall sign and deliver to the Representative a lock-up agreement substantially in the form of this lock-up agreement and (iii) no filing under Section 16(a) of the U.S. Securities Exchange Act of 1934, as amended shall be required or shall be voluntarily made (collectively, “Permitted Transfers”). For purposes of this paragraph, the term “Change of Control” shall mean any transaction or series of related transactions pursuant to which any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act) becomes the “beneficial owner” (as such term is defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the total voting power of the Shares of the Company on a fully diluted basis. The undersigned also agrees and consents to the entry of stop transfer instructions with the Company’s transfer agent and registrar against the transfer of the undersigned’s Lock-Up Securities except in compliance with this lock-up agreement.

The undersigned agrees that, prior to engaging in any transaction or taking any other action that is subject to the terms of this lock-up agreement (for the avoidance of doubt, excluding any transaction or other action in connection with a Permitted Transfer) during the period from the date hereof to the expiration of the initial Lock-Up Period, the undersigned will give notice thereof to the Company and will not consummate any such transaction or take any such action unless it has received written confirmation from the Company that the Lock-Up Period has expired.

The undersigned agrees that (i) the foregoing restrictions shall be equally applicable to any issuer-directed or “friends and family” Shares that the undersigned may purchase in the Initial Public Offering, (ii) at least three (3) business days before the effective date of any release or waiver of the foregoing restrictions in connection with a transfer of Lock-Up Securities, the Representative will notify the Company of the impending release or waiver. Any release or waiver granted by the Representative hereunder to any such officer or director shall only be effective two (2) business days after the publication date of such press release. The provisions of this paragraph will not apply if (a) the release or waiver is effected solely to permit a transfer of Lock-Up Securities not for consideration or in connection with any other Permitted Transfer and (b) the transferee has agreed in writing to be bound by a lock-up agreement substantially in the form of this lock-up agreement.

No provision in this agreement shall be deemed to restrict or prohibit the exercise, exchange or conversion by the undersigned of any securities exercisable or exchangeable for or convertible into Shares, as applicable; provided that the undersigned does not transfer the Shares acquired on such exercise, exchange or conversion during the Lock-Up Period, unless in connection with a Permitted Transfer or in a transfer otherwise permitted pursuant to the terms of this lock-up agreement. In addition, no provision herein shall be deemed to restrict or prohibit the entry into or modification of a so-called “10b5-1” plan at any time (other than the entry into or modification of such a plan in such a manner as to cause the sale of any Lock-Up Securities within the Lock-Up Period).

The undersigned understands that the Company and the Representative are relying upon this lock-up agreement in proceeding toward consummation of the Initial Public Offering. The undersigned further understands that this lock-up agreement is irrevocable and shall be binding upon the undersigned’s heirs, successors and assigns.

The undersigned understands that, if the Underwriting Agreement does not become effective, or if the Underwriting Agreement (other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Shares to be sold thereunder, then this lock-up agreement shall be void and of no further force or effect.

Whether or not the Initial Public Offering actually occurs depends on a number of factors, including market conditions. The Initial Public Offering will only be made pursuant to an Underwriting Agreement, the terms of which are subject to negotiation between the Company and the Representative.

This lock-up agreement shall be governed by and construed in accordance with the internal laws of the State of New York, without regard to the conflict of laws principles thereof. Delivery of a signed copy of this lock-up agreement by facsimile or e-mail/.pdf transmission shall be effective as the delivery of the original hereof.

[SIGNATURE PAGE TO FOLLOW]

30